Latest news with #GlandPharmaLtd
Mint
06-08-2025
- Business
- Mint
Gland Pharma share price rises 6% post Q1 results: Should you buy or sell the stock?
Stock Market Today: Gland Pharma share price gained more than 6% in the morning trades on Wednesday, post Q1 results On Tuesday, August 5, after the market hours, Gland Pharma Ltd. reported a strong rise in net profit for the first quarter of FY26. The Gland Pharma net profit jumped 49.9% year-on-year to ₹ 215.4 crore, from ₹ 143.7 crore in the same period last year. The net profit, helped by operating performance, beat analyst expectations. Analysts at Motilal Oswal Financial Services said that while Gland Pharma posted revenue in line with our estimate in 1QFY26, EBITDA and net profit exceeded their estimates by 13% and 16%, respectively. Gland Pharma Net sales at ₹ 1505.6 crore grew 7.4% year-on-year. Better operational efficiency at Cenexi and strong traction in key geographies, such as Europe, Canada, Australia, New Zealand, and the rest of the world, contributed to the quarter's improved performance. Cenexi is a European pharmaceutical Contract Development and Manufacturing Organization (CDMO) acquired by Gland Pharma to expand its presence in the European market. Jefferies India Private Limited said that Gland 1Q results were driven by a turnaround in Cenexi, which benefitted from the launch of higher-value projects and better capacity utilization. The US saw a soft quarter, but management expects a stronger second half and maintained an overall mid-teens revenue growth guidance.
Business Standard
29-07-2025
- Business
- Business Standard
Gland Pharma Ltd up for third consecutive session
Gland Pharma Ltd is quoting at Rs 2085.7, up 1.62% on the day as on 12:49 IST on the NSE. The stock is up 1.31% in last one year as compared to a 0.63% jump in NIFTY and a 6.77% jump in the Nifty Pharma index. Gland Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 2085.7, up 1.62% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.08% on the day, quoting at 24701.85. The Sensex is at 80911.87, up 0.03%. Gland Pharma Ltd has gained around 13.75% in last one month. Meanwhile, Nifty Pharma index of which Gland Pharma Ltd is a constituent, has gained around 4.35% in last one month and is currently quoting at 22761.15, up 1.04% on the day. The volume in the stock stood at 1.9 lakh shares today, compared to the daily average of 4.88 lakh shares in last one month. The PE of the stock is 31.02 based on TTM earnings ending March 25.
Business Standard
17-07-2025
- Business
- Business Standard
Gland Pharma Ltd up for five straight sessions
Gland Pharma Ltd is quoting at Rs 1994.3, up 1.19% on the day as on 12:44 IST on the NSE. The stock is down 0.77% in last one year as compared to a 1.58% gain in NIFTY and a 9.53% gain in the Nifty Pharma. Gland Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 1994.3, up 1.19% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.07% on the day, quoting at 25193.55. The Sensex is at 82521.43, down 0.14%. Gland Pharma Ltd has added around 14.97% in last one month. Meanwhile, Nifty Pharma index of which Gland Pharma Ltd is a constituent, has added around 5.37% in last one month and is currently quoting at 22593.9, up 0.68% on the day. The volume in the stock stood at 5.06 lakh shares today, compared to the daily average of 3.63 lakh shares in last one month. The PE of the stock is 29.8 based on TTM earnings ending March 25.
&w=3840&q=100)
Business Standard
14-07-2025
- Business
- Business Standard
Gland Pharma shares rise on GMP nod for Telangana manufacturing unit
Shares of Gland Pharma Ltd. rose over 2 per cent in Monday's intraday session after the company received a Good Manufacturing Practices certification from the Danish Medicines Agency for its Pashamylaram facility in Telangana. The pharmaceutical company's stock rose as much as 2.12 per cent during the day to ₹1898.4 per share, the biggest intraday fall since July 1 this year. The stock pared gains to trade 1.27 per cent higher at ₹1,882.7 apiece, compared to a 0.30 per cent decline in Nifty 50 as of 9:40 AM. Shares of the company trade at the highest level since January 7 this year and currently trade at 4 times the average 30-day trading volume, according to Bloomberg. The counter has risen 5.5 per cent this year, compared to a 6 per cent advance in the benchmark Nifty 50. Gland Pharma has a total market capitalisation of ₹30,893.48 crore. Gland Pharma's Pashamylaram facility gets GMP certification The headcare major said that its Pashamylaram facility has received a 'Good Manufacturing Practices' (GMP) compliance certificate from the Danish Medicines Agency, according to an exchange filing. The certification was granted in connection with marketing authorisations that list manufacturers located outside the European Economic Area (EEA), it said. The approval covers aseptically prepared powder for injection, infusion, and inhalation, strengthening the company's regulatory credentials in European markets. Gland Pharma Q4 results Gland Pharma reported a 3 per cent year-on-year (YoY) decline in its consolidated net profit to ₹186.5 crore for the fourth quarter ended March 2025 (Q4FY25), compared to ₹192.4 crore in the same period last year. Revenue from operations fell 7 per cent YoY to ₹1,424.9 crore from ₹1,537.5 crore. The company's Ebitda stood at ₹347.5 crore, marginally down from ₹358.7 crore a year ago. About Gland Pharma Gland Pharma is a small-molecule generic injectables-focused company, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets in the rest of the world. The firm has seven manufacturing facilities in India, comprising four facilities for finished formulations and three API facilities.
Business Standard
26-06-2025
- Business
- Business Standard
Gland Pharma Ltd soars 0.08%, gains for fifth straight session
Gland Pharma Ltd is quoting at Rs 1781.7, up 0.08% on the day as on 12:44 IST on the NSE. The stock is down 1.96% in last one year as compared to a 5.65% jump in NIFTY and a 11.34% jump in the Nifty Pharma. Gland Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 1781.7, up 0.08% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.62% on the day, quoting at 25402.2. The Sensex is at 83287.99, up 0.64%. Gland Pharma Ltd has gained around 16.61% in last one month. Meanwhile, Nifty Pharma index of which Gland Pharma Ltd is a constituent, has gained around 0.94% in last one month and is currently quoting at 21804.8, down 0.35% on the day. The volume in the stock stood at 1.35 lakh shares today, compared to the daily average of 1.72 lakh shares in last one month. The PE of the stock is 26.95 based on TTM earnings ending March 25.
